KAYALOGY.ch is a Swiss ‘Deep-Tech MedAI’ company building a medical AI platform aimed at early cancer detection through clinical validation and scalable deployment. The platform is described as browser-native and ‘zero install,’ enabling research access without local installation. Kayalogy positions its approach as privacy-first, emphasizing a ‘deletion-first model’ and a focus on privacy & ethics for sensitive medical data.
From a workflow perspective, the company states that its platform is built for imaging workflows and supports early detection programs by offering verifiable, reproducible evaluation. Kayalogy presents the product as partner-driven for clinical validation, with evidence-first and compliance-aware features, including measurable performance targets, transparent limitations, and a roadmap aligned with medical requirements. The company also notes that it is under development and intended for research, demonstration, and evaluation use only - not for clinical use.
